Overall, KLS positive and bulk bone marrow cells from ENU-induced AML and MDS mouse models were capable of establishing secondary transplants, but did not lead to rapidly fatal disease or recapitulation of the primary disease phenotype. The gene discussed is RPS6KB2; the disease is myelodysplastic syndrome.